National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care
Summary Hepatitis C virus (HCV) infection is a major health problem in Egypt as the nation bears the highest prevalence rate worldwide. This necessitated establishing a novel model of care (MOC) to contain the epidemic, deliver patient care and ensure global treatment access. In this review, we desc...
Gespeichert in:
Veröffentlicht in: | Journal of viral hepatitis 2017-04, Vol.24 (4), p.262-267 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 267 |
---|---|
container_issue | 4 |
container_start_page | 262 |
container_title | Journal of viral hepatitis |
container_volume | 24 |
creator | El‐Akel, W. El‐Sayed, M. H. El Kassas, M. El‐Serafy, M. Khairy, M. Elsaeed, K. Kabil, K. Hassany, M. Shawky, A. Yosry, A. Shaker, M. K. ElShazly, Y. Waked, I. Esmat, G. Doss, W. |
description | Summary
Hepatitis C virus (HCV) infection is a major health problem in Egypt as the nation bears the highest prevalence rate worldwide. This necessitated establishing a novel model of care (MOC) to contain the epidemic, deliver patient care and ensure global treatment access. In this review, we describe the process of development of the Egyptian model and future strategies for sustainability. Although the magnitude of the HCV problem was known for many years, the HCV MOC only came into being in 2006 with the establishment of the National Committee for Control of Viral Hepatitis (NCCVH) to set up and implement a national control strategy for the disease and other causes of viral hepatitis. The strategy outlines best practices for patient care delivery by applying a set of service principles through identified clinical streams and patient flow continuums. The Egyptian national viral hepatitis treatment programme is considered one of the most successful and effective public health programmes. To date, more than one million patients were evaluated and more than 850 000 received treatment under the umbrella of the programme since 2006. The NCCVH has been successful in establishing a strong infrastructure for controlling viral hepatitis in Egypt. It established a nationwide network of digitally connected viral hepatitis‐specialized treatment centres covering the country map to enhance treatment access. Practice guidelines suiting local circumstances were issued and regularly updated and are applied in all affiliated centres. This review illustrates the model and the successful Egyptian experience. It sets an exemplar for states, organizations and policy‐makers setting up programmes for care and management of people with hepatitis C. |
doi_str_mv | 10.1111/jvh.12668 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1863698247</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1863698247</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3538-4b288dd932929ca92c5729a46f34f535232d9305ea6ec11a4805ec0f1cf5b7573</originalsourceid><addsrcrecordid>eNp1kMtKAzEUhoMotlYXvoAE3Ohi2lynGXelVKsU3Vi3Ic1k2ilzM5mp9O3NOFVEMJtzyPnyc_IBcInREPsz2u42Q0zCUByBPqYhD4iI6HHbcxIgjlgPnDm3RQhTwvEp6BGBGUeU9MHyWdVpWagM1taoOjdFDStbrq3KcwPLBG5M5Yk6dXAK0wLO1vuqvoPzX7e71DYO5mVssvaBVtacg5NEZc5cHOoALO9nr9N5sHh5eJxOFoGmnIqArYgQcRxREpFIq4hoPiaRYmFCWcL98pT4IeJGhUZjrJjwvUYJ1glfjfmYDsBNl-tXfm-Mq2WeOm2yTBWmbJzEIqRhJAhr0es_6LZsrP94SwnsZTDEPHXbUdqWzlmTyMqmubJ7iZFsXUvvWn659uzVIbFZ5Sb-Ib_lemDUAR9pZvb_J8mnt3kX-Qkqh4ZD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1881032404</pqid></control><display><type>article</type><title>National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>El‐Akel, W. ; El‐Sayed, M. H. ; El Kassas, M. ; El‐Serafy, M. ; Khairy, M. ; Elsaeed, K. ; Kabil, K. ; Hassany, M. ; Shawky, A. ; Yosry, A. ; Shaker, M. K. ; ElShazly, Y. ; Waked, I. ; Esmat, G. ; Doss, W.</creator><creatorcontrib>El‐Akel, W. ; El‐Sayed, M. H. ; El Kassas, M. ; El‐Serafy, M. ; Khairy, M. ; Elsaeed, K. ; Kabil, K. ; Hassany, M. ; Shawky, A. ; Yosry, A. ; Shaker, M. K. ; ElShazly, Y. ; Waked, I. ; Esmat, G. ; Doss, W.</creatorcontrib><description>Summary
Hepatitis C virus (HCV) infection is a major health problem in Egypt as the nation bears the highest prevalence rate worldwide. This necessitated establishing a novel model of care (MOC) to contain the epidemic, deliver patient care and ensure global treatment access. In this review, we describe the process of development of the Egyptian model and future strategies for sustainability. Although the magnitude of the HCV problem was known for many years, the HCV MOC only came into being in 2006 with the establishment of the National Committee for Control of Viral Hepatitis (NCCVH) to set up and implement a national control strategy for the disease and other causes of viral hepatitis. The strategy outlines best practices for patient care delivery by applying a set of service principles through identified clinical streams and patient flow continuums. The Egyptian national viral hepatitis treatment programme is considered one of the most successful and effective public health programmes. To date, more than one million patients were evaluated and more than 850 000 received treatment under the umbrella of the programme since 2006. The NCCVH has been successful in establishing a strong infrastructure for controlling viral hepatitis in Egypt. It established a nationwide network of digitally connected viral hepatitis‐specialized treatment centres covering the country map to enhance treatment access. Practice guidelines suiting local circumstances were issued and regularly updated and are applied in all affiliated centres. This review illustrates the model and the successful Egyptian experience. It sets an exemplar for states, organizations and policy‐makers setting up programmes for care and management of people with hepatitis C.</description><identifier>ISSN: 1352-0504</identifier><identifier>EISSN: 1365-2893</identifier><identifier>DOI: 10.1111/jvh.12668</identifier><identifier>PMID: 28145032</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Antiviral Agents - therapeutic use ; chronic HCV ; Delivery of Health Care - organization & administration ; Disease Management ; Egypt ; Egypt - epidemiology ; Hepatitis C, Chronic - diagnosis ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - epidemiology ; Humans ; model of care ; National Committee for Control of Viral Hepatitis ; Practice Guidelines as Topic ; Public Health Administration - methods</subject><ispartof>Journal of viral hepatitis, 2017-04, Vol.24 (4), p.262-267</ispartof><rights>2017 John Wiley & Sons Ltd</rights><rights>2017 John Wiley & Sons Ltd.</rights><rights>Copyright © 2017 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3538-4b288dd932929ca92c5729a46f34f535232d9305ea6ec11a4805ec0f1cf5b7573</citedby><cites>FETCH-LOGICAL-c3538-4b288dd932929ca92c5729a46f34f535232d9305ea6ec11a4805ec0f1cf5b7573</cites><orcidid>0000-0002-3396-6894</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjvh.12668$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjvh.12668$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28145032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El‐Akel, W.</creatorcontrib><creatorcontrib>El‐Sayed, M. H.</creatorcontrib><creatorcontrib>El Kassas, M.</creatorcontrib><creatorcontrib>El‐Serafy, M.</creatorcontrib><creatorcontrib>Khairy, M.</creatorcontrib><creatorcontrib>Elsaeed, K.</creatorcontrib><creatorcontrib>Kabil, K.</creatorcontrib><creatorcontrib>Hassany, M.</creatorcontrib><creatorcontrib>Shawky, A.</creatorcontrib><creatorcontrib>Yosry, A.</creatorcontrib><creatorcontrib>Shaker, M. K.</creatorcontrib><creatorcontrib>ElShazly, Y.</creatorcontrib><creatorcontrib>Waked, I.</creatorcontrib><creatorcontrib>Esmat, G.</creatorcontrib><creatorcontrib>Doss, W.</creatorcontrib><title>National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care</title><title>Journal of viral hepatitis</title><addtitle>J Viral Hepat</addtitle><description>Summary
Hepatitis C virus (HCV) infection is a major health problem in Egypt as the nation bears the highest prevalence rate worldwide. This necessitated establishing a novel model of care (MOC) to contain the epidemic, deliver patient care and ensure global treatment access. In this review, we describe the process of development of the Egyptian model and future strategies for sustainability. Although the magnitude of the HCV problem was known for many years, the HCV MOC only came into being in 2006 with the establishment of the National Committee for Control of Viral Hepatitis (NCCVH) to set up and implement a national control strategy for the disease and other causes of viral hepatitis. The strategy outlines best practices for patient care delivery by applying a set of service principles through identified clinical streams and patient flow continuums. The Egyptian national viral hepatitis treatment programme is considered one of the most successful and effective public health programmes. To date, more than one million patients were evaluated and more than 850 000 received treatment under the umbrella of the programme since 2006. The NCCVH has been successful in establishing a strong infrastructure for controlling viral hepatitis in Egypt. It established a nationwide network of digitally connected viral hepatitis‐specialized treatment centres covering the country map to enhance treatment access. Practice guidelines suiting local circumstances were issued and regularly updated and are applied in all affiliated centres. This review illustrates the model and the successful Egyptian experience. It sets an exemplar for states, organizations and policy‐makers setting up programmes for care and management of people with hepatitis C.</description><subject>Antiviral Agents - therapeutic use</subject><subject>chronic HCV</subject><subject>Delivery of Health Care - organization & administration</subject><subject>Disease Management</subject><subject>Egypt</subject><subject>Egypt - epidemiology</subject><subject>Hepatitis C, Chronic - diagnosis</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - epidemiology</subject><subject>Humans</subject><subject>model of care</subject><subject>National Committee for Control of Viral Hepatitis</subject><subject>Practice Guidelines as Topic</subject><subject>Public Health Administration - methods</subject><issn>1352-0504</issn><issn>1365-2893</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtKAzEUhoMotlYXvoAE3Ohi2lynGXelVKsU3Vi3Ic1k2ilzM5mp9O3NOFVEMJtzyPnyc_IBcInREPsz2u42Q0zCUByBPqYhD4iI6HHbcxIgjlgPnDm3RQhTwvEp6BGBGUeU9MHyWdVpWagM1taoOjdFDStbrq3KcwPLBG5M5Yk6dXAK0wLO1vuqvoPzX7e71DYO5mVssvaBVtacg5NEZc5cHOoALO9nr9N5sHh5eJxOFoGmnIqArYgQcRxREpFIq4hoPiaRYmFCWcL98pT4IeJGhUZjrJjwvUYJ1glfjfmYDsBNl-tXfm-Mq2WeOm2yTBWmbJzEIqRhJAhr0es_6LZsrP94SwnsZTDEPHXbUdqWzlmTyMqmubJ7iZFsXUvvWn659uzVIbFZ5Sb-Ib_lemDUAR9pZvb_J8mnt3kX-Qkqh4ZD</recordid><startdate>201704</startdate><enddate>201704</enddate><creator>El‐Akel, W.</creator><creator>El‐Sayed, M. H.</creator><creator>El Kassas, M.</creator><creator>El‐Serafy, M.</creator><creator>Khairy, M.</creator><creator>Elsaeed, K.</creator><creator>Kabil, K.</creator><creator>Hassany, M.</creator><creator>Shawky, A.</creator><creator>Yosry, A.</creator><creator>Shaker, M. K.</creator><creator>ElShazly, Y.</creator><creator>Waked, I.</creator><creator>Esmat, G.</creator><creator>Doss, W.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3396-6894</orcidid></search><sort><creationdate>201704</creationdate><title>National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care</title><author>El‐Akel, W. ; El‐Sayed, M. H. ; El Kassas, M. ; El‐Serafy, M. ; Khairy, M. ; Elsaeed, K. ; Kabil, K. ; Hassany, M. ; Shawky, A. ; Yosry, A. ; Shaker, M. K. ; ElShazly, Y. ; Waked, I. ; Esmat, G. ; Doss, W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3538-4b288dd932929ca92c5729a46f34f535232d9305ea6ec11a4805ec0f1cf5b7573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antiviral Agents - therapeutic use</topic><topic>chronic HCV</topic><topic>Delivery of Health Care - organization & administration</topic><topic>Disease Management</topic><topic>Egypt</topic><topic>Egypt - epidemiology</topic><topic>Hepatitis C, Chronic - diagnosis</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - epidemiology</topic><topic>Humans</topic><topic>model of care</topic><topic>National Committee for Control of Viral Hepatitis</topic><topic>Practice Guidelines as Topic</topic><topic>Public Health Administration - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El‐Akel, W.</creatorcontrib><creatorcontrib>El‐Sayed, M. H.</creatorcontrib><creatorcontrib>El Kassas, M.</creatorcontrib><creatorcontrib>El‐Serafy, M.</creatorcontrib><creatorcontrib>Khairy, M.</creatorcontrib><creatorcontrib>Elsaeed, K.</creatorcontrib><creatorcontrib>Kabil, K.</creatorcontrib><creatorcontrib>Hassany, M.</creatorcontrib><creatorcontrib>Shawky, A.</creatorcontrib><creatorcontrib>Yosry, A.</creatorcontrib><creatorcontrib>Shaker, M. K.</creatorcontrib><creatorcontrib>ElShazly, Y.</creatorcontrib><creatorcontrib>Waked, I.</creatorcontrib><creatorcontrib>Esmat, G.</creatorcontrib><creatorcontrib>Doss, W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of viral hepatitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El‐Akel, W.</au><au>El‐Sayed, M. H.</au><au>El Kassas, M.</au><au>El‐Serafy, M.</au><au>Khairy, M.</au><au>Elsaeed, K.</au><au>Kabil, K.</au><au>Hassany, M.</au><au>Shawky, A.</au><au>Yosry, A.</au><au>Shaker, M. K.</au><au>ElShazly, Y.</au><au>Waked, I.</au><au>Esmat, G.</au><au>Doss, W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care</atitle><jtitle>Journal of viral hepatitis</jtitle><addtitle>J Viral Hepat</addtitle><date>2017-04</date><risdate>2017</risdate><volume>24</volume><issue>4</issue><spage>262</spage><epage>267</epage><pages>262-267</pages><issn>1352-0504</issn><eissn>1365-2893</eissn><abstract>Summary
Hepatitis C virus (HCV) infection is a major health problem in Egypt as the nation bears the highest prevalence rate worldwide. This necessitated establishing a novel model of care (MOC) to contain the epidemic, deliver patient care and ensure global treatment access. In this review, we describe the process of development of the Egyptian model and future strategies for sustainability. Although the magnitude of the HCV problem was known for many years, the HCV MOC only came into being in 2006 with the establishment of the National Committee for Control of Viral Hepatitis (NCCVH) to set up and implement a national control strategy for the disease and other causes of viral hepatitis. The strategy outlines best practices for patient care delivery by applying a set of service principles through identified clinical streams and patient flow continuums. The Egyptian national viral hepatitis treatment programme is considered one of the most successful and effective public health programmes. To date, more than one million patients were evaluated and more than 850 000 received treatment under the umbrella of the programme since 2006. The NCCVH has been successful in establishing a strong infrastructure for controlling viral hepatitis in Egypt. It established a nationwide network of digitally connected viral hepatitis‐specialized treatment centres covering the country map to enhance treatment access. Practice guidelines suiting local circumstances were issued and regularly updated and are applied in all affiliated centres. This review illustrates the model and the successful Egyptian experience. It sets an exemplar for states, organizations and policy‐makers setting up programmes for care and management of people with hepatitis C.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28145032</pmid><doi>10.1111/jvh.12668</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3396-6894</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1352-0504 |
ispartof | Journal of viral hepatitis, 2017-04, Vol.24 (4), p.262-267 |
issn | 1352-0504 1365-2893 |
language | eng |
recordid | cdi_proquest_miscellaneous_1863698247 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Antiviral Agents - therapeutic use chronic HCV Delivery of Health Care - organization & administration Disease Management Egypt Egypt - epidemiology Hepatitis C, Chronic - diagnosis Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - epidemiology Humans model of care National Committee for Control of Viral Hepatitis Practice Guidelines as Topic Public Health Administration - methods |
title | National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A05%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=National%20treatment%20programme%20of%20hepatitis%20C%20in%20Egypt:%20Hepatitis%20C%20virus%20model%20of%20care&rft.jtitle=Journal%20of%20viral%20hepatitis&rft.au=El%E2%80%90Akel,%20W.&rft.date=2017-04&rft.volume=24&rft.issue=4&rft.spage=262&rft.epage=267&rft.pages=262-267&rft.issn=1352-0504&rft.eissn=1365-2893&rft_id=info:doi/10.1111/jvh.12668&rft_dat=%3Cproquest_cross%3E1863698247%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1881032404&rft_id=info:pmid/28145032&rfr_iscdi=true |